Clinical Trial

HPC Offered for PRESERVE Expansion

Name: HPC Offered for PRESERVE Expansion — clinical trial record (NCT07145411)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HOPE

Recruiting

View on ClinicalTrials.gov →

Summary

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

Trial Details

NCT Number	NCT07145411
Lead Sponsor	Ossium Health, Inc.
Conditions	Bone Marrow Transplant (BMT)
Enrollment	10 participants
Start Date	2024-06-27
Primary Completion	2027-08 (estimated)
Study Completion	2029-08 (estimated)
Updated on ClinicalTrials.gov	2025-08-28